What a week to round up. Against a backdrop of regulatory approvals, strategic deals, and R&D initiatives, a fresh salvo of life sciences IPOs signaled a resurgence in public offerings already running ahead of last year’s pace. We also saw moves... Read more »
Zillow could be pursuing its biggest online real estate rival, Trulia, if a report from Bloomberg is to be believed. Another Northwest M&A deal is also going down: KeyCorp has an agreement to acquire Pacific Crest Securities. Meanwhile, big companies including... Read more »
When the anti-utopian book The Circle, the latest novel from McSweeney’s founder Dave Eggers, came out last October, reviewers hailed it as a “provocative” and “foreboding” warning about the spiritual costs of excessive sharing and transparency on the Internet. The... Read more »
When Boston-based Summit Partners acquired a majority stake in Minneapolis-based healthtech firm Ability Network in April for $550 million, the deal got no press in nearby Wisconsin. That wasn’t a surprise: Ability Network has no major presence in the Badger State.... Read more »
Oracle is the latest technology giant to set up shop in Cloud City, WA—also known as Seattle—in search of talented engineers.
The Redwood Shores, CA, enterprise IT giant is planning to hire 100 engineers to staff a new Oracle Cloud Infrastructure... Read more »
Denis O’Dwyer wants to bring the power of the Internet to the Great Outdoors.
His startup, Wide Open Spaces, is designed as an online community targeting hunters and fishing enthusiasts, a one-stop shop to buy gear, research new techniques, and discover... Read more »
It’s probably just a matter of time before a new company combines the rapidly advancing technologies of genome sequencing, genetic diagnostics, and Big Data to become the Google of bioinformatics.
Cypher Genomics would like to claim that title, though it’s too... Read more »
Sarepta Therapeutics is already one of the most controversial, volatile stocks in the biotech sector. And the Cambridge, MA-based company is in for another rocky day today, as a regulatory filing revealed that the company has axed chief scientific officer and... Read more »